Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-16 Sale | 2026-09-18 4:03 pm | CRESCENT BIOPHARMA INC. | CBIO | Lynch Ryan See Remarks | 240 | $17.9 | $4,296 | 13,631 (Direct) | View |
| 2026-09-16 Sale | 2026-09-18 4:03 pm | CRESCENT BIOPHARMA INC. | CBIO | Pinkas Jan Chief Scientific Officer | 658 | $17.9 | $11,778 | 21,581 (Direct) | View |
| 2026-09-16 Sale | 2026-09-18 4:02 pm | CRESCENT BIOPHARMA INC. | CBIO | Im Ellie Eunkyung Chief Medical Officer | 623 | $17.9 | $11,152 | 21,446 (Direct) | View |
| 2026-09-16 Sale | 2026-09-18 4:02 pm | CRESCENT BIOPHARMA INC. | CBIO | Scalzo Richard William Chief Financial Officer | 568 | $17.9 | $10,167 | 19,730 (Direct) | View |
| 2026-09-16 Sale | 2026-09-18 4:02 pm | CRESCENT BIOPHARMA INC. | CBIO | Bispham Barbara Harlin See Remarks | 620 | $17.9 | $11,098 | 18,710 (Direct) | View |
| 2026-09-16 Sale | 2026-09-18 4:02 pm | CRESCENT BIOPHARMA INC. | CBIO | Brumm Joshua T Chief Executive Officer | 9,447 | $16.91 | $159,775 | 271,765 (Direct) | View |
| 2026-09-16 Sale | 2026-09-18 4:01 pm | CRESCENT BIOPHARMA INC. | CBIO | McNeill Jonathan President and COO | 4,570 | $16.9 | $77,235 | 134,588 (Direct) | View |
| 2026-07-16 Purchase | 2026-07-20 5:30 pm | CRESCENT BIOPHARMA INC. | CBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 853,450 | $14.5 | $12,375,025 | 5,895,353 (Indirect) | View |
| 2026-06-22 Sale | 2026-06-23 4:04 pm | CRESCENT BIOPHARMA INC. | CBIO | Lynch Ryan See Remarks | 465 | $17.99 | $8,365 | 13,871 (Direct) | View |
| 2026-06-22 Sale | 2026-06-23 4:04 pm | CRESCENT BIOPHARMA INC. | CBIO | Pinkas Jan Chief Scientific Officer | 1,288 | $17.99 | $23,171 | 22,239 (Direct) | View |
| 2026-06-22 Sale | 2026-06-23 4:03 pm | CRESCENT BIOPHARMA INC. | CBIO | Scalzo Richard William Chief Financial Officer | 1,112 | $17.99 | $20,005 | 20,298 (Direct) | View |
| 2026-06-22 Sale | 2026-06-23 4:03 pm | CRESCENT BIOPHARMA INC. | CBIO | Bispham Barbara Harlin See Remarks | 1,218 | $17.99 | $21,912 | 19,330 (Direct) | View |
| 2026-06-22 Sale | 2026-06-23 4:02 pm | CRESCENT BIOPHARMA INC. | CBIO | Im Ellie Eunkyung Chief Medical Officer | 1,219 | $17.99 | $21,930 | 22,069 (Direct) | View |
| 2026-06-22 Sale | 2026-06-23 4:02 pm | CRESCENT BIOPHARMA INC. | CBIO | McNeill Jonathan President and COO | 20,549 | $17.99 | $369,677 | 139,158 (Direct) | View |
| 2026-06-22 Sale | 2026-06-23 4:01 pm | CRESCENT BIOPHARMA INC. | CBIO | Brumm Joshua T Chief Executive Officer | 42,305 | $17.99 | $761,067 | 281,212 (Direct) | View |
| 2025-12-04 Purchase | 2025-12-08 4:30 pm | CRESCENT BIOPHARMA INC. | CBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 1,360,000 | $13.41 | $18,237,600 | 4,516,006 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-02 Option Award | 2026-06-03 7:48 pm | N/A 2036-06-02 | CRESCENT BIOPHARMA INC. | CBIO | Violin Jonathan Director | 11,050 | $0 | 11,050 (Direct) | View |
| 2026-06-02 Option Award | 2026-06-03 7:48 pm | N/A 2036-06-02 | CRESCENT BIOPHARMA INC. | CBIO | Lubner David Charles Director | 11,050 | $0 | 11,050 (Direct) | View |
| 2026-06-02 Option Award | 2026-06-03 7:47 pm | N/A 2036-06-02 | CRESCENT BIOPHARMA INC. | CBIO | Balcom Alexandra Director | 11,050 | $0 | 11,050 (Direct) | View |
| 2026-06-02 Option Award | 2026-06-03 7:47 pm | N/A 2036-06-02 | CRESCENT BIOPHARMA INC. | CBIO | Moran Susan Director | 11,050 | $0 | 11,050 (Direct) | View |
| 2026-06-02 Option Award | 2026-06-03 7:46 pm | N/A 2036-06-02 | CRESCENT BIOPHARMA INC. | CBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Harwin Peter Evan Kiselak Tomas Director 10% Owner | 11,050 | $0 | 11,050 (Indirect) | View |
| 2025-12-15 Option Award | 2025-12-17 4:49 pm | N/A 2035-12-15 | CRESCENT BIOPHARMA INC. | CBIO | Pinkas Jan Chief Scientific Officer | 92,532 | $0 | 92,532 (Direct) | View |
| 2025-12-15 Option Award | 2025-12-17 4:47 pm | N/A 2035-12-15 | CRESCENT BIOPHARMA INC. | CBIO | Doughty Christopher Grant Chief Business Officer | 81,569 | $0 | 121,049 (Direct) | View |
| 2025-12-15 Option Award | 2025-12-17 4:46 pm | N/A 2035-12-15 | CRESCENT BIOPHARMA INC. | CBIO | Brumm Joshua T Chief Executive Officer | 235,584 | $0 | 503,984 (Direct) | View |
| 2025-12-15 Option Award | 2025-12-17 4:45 pm | N/A 2035-12-15 | CRESCENT BIOPHARMA INC. | CBIO | Scalzo Richard William Chief Financial Officer | 77,110 | $0 | 77,110 (Direct) | View |
| 2025-12-15 Option Award | 2025-12-17 4:43 pm | N/A 2035-12-15 | CRESCENT BIOPHARMA INC. | CBIO | McNeill Jonathan President and COO | 103,536 | $0 | 237,736 (Direct) | View |
| 2025-12-15 Option Award | 2025-12-17 4:41 pm | N/A 2035-12-15 | CRESCENT BIOPHARMA INC. | CBIO | Im Ellie Eunkyung Chief Medical Officer | 86,488 | $0 | 86,488 (Direct) | View |
| 2025-12-15 Option Award | 2025-12-17 4:38 pm | N/A 2035-12-15 | CRESCENT BIOPHARMA INC. | CBIO | Lynch Ryan See Remarks | 45,890 | $0 | 45,890 (Direct) | View |
| 2025-12-15 Option Award | 2025-12-17 4:35 pm | N/A 2035-12-15 | CRESCENT BIOPHARMA INC. | CBIO | Bispham Barbara Harlin See Remarks | 90,607 | $0 | 90,607 (Direct) | View |
| 2025-12-08 Option Award | 2025-12-10 4:37 pm | N/A 2035-12-08 | CRESCENT BIOPHARMA INC. | CBIO | McNeill Jonathan President and COO | 172,836 | $0 | 172,836 (Direct) | View |
| 2025-12-08 Option Award | 2025-12-10 4:35 pm | N/A 2035-12-08 | CRESCENT BIOPHARMA INC. | CBIO | Brumm Joshua T Chief Executive Officer | 345,672 | $0 | 345,672 (Direct) | View |
| 2025-07-16 Option Award | 2025-07-16 7:11 pm | N/A 2035-07-16 | CRESCENT BIOPHARMA INC. | CBIO | Pinkas Jan Chief Scientific Officer | 142,474 | $0 | 142,474 (Direct) | View |
Ownership | 2025-06-30 4:21 pm | N/A 2035-04-01 | CRESCENT BIOPHARMA INC. | CBIO | Im Ellie Eunkyung Chief Medical Officer | 0 | $0 | 257,822 (Direct) | View |
Ownership | 2025-06-30 4:16 pm | N/A 2035-01-13 | CRESCENT BIOPHARMA INC. | CBIO | Bispham Barbara Harlin See Remarks | 0 | $0 | 106,235 (Direct) | View |
| 2025-06-23 Option Award | 2025-06-23 6:51 pm | N/A 2035-06-23 | GLYCOMIMETICS INC | CBIO | Moran Susan Director | 9,023 | $0 | 9,023 (Direct) | View |
| 2025-06-23 Option Award | 2025-06-23 6:48 pm | N/A 2035-06-23 | GLYCOMIMETICS INC | CBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 9,023 | $0 | 9,023 (Indirect) | View |
| 2025-06-23 Option Award | 2025-06-23 6:46 pm | N/A 2035-06-23 | GLYCOMIMETICS INC | CBIO | Violin Jonathan Director | 9,023 | $0 | 9,023 (Direct) | View |
| 2025-06-23 Option Award | 2025-06-23 6:43 pm | N/A 2035-06-23 | GLYCOMIMETICS INC | CBIO | Balcom Alexandra Director | 9,023 | $0 | 9,023 (Direct) | View |
| 2025-06-23 Option Award | 2025-06-23 6:41 pm | N/A 2035-06-23 | GLYCOMIMETICS INC | CBIO | Lubner David Charles Director | 9,023 | $0 | 9,023 (Direct) | View |